Stonebridge Financial Group (Pennsylvania)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.63M Buy
15,561
+498
+3% +$170K 0.43% 60
2026
Q1
$5.3M Buy
15,063
+348
+2% +$124K 0.44% 62
2025
Q4
$4.82M Buy
14,715
+881
+6% +$279K 0.41% 65
2025
Q3
$3.9M Buy
13,834
+182
+1% +$52.8K 0.34% 80
2025
Q2
$3.81M Buy
13,652
+442
+3% +$125K 0.37% 75
2025
Q1
$4.12M Buy
13,210
+886
+7% +$262K 0.44% 65
2024
Q4
$3.21M Buy
+12,324
New +$3.66M 0.35% 74

Other funds holding AMGN

Stonebridge Financial Group (Pennsylvania)'s AMGN Position: Q2 2026 in Review

Stonebridge Financial Group (Pennsylvania) increased its Amgen (AMGN) stake by 3.3% in Q2 2026, buying an estimated $170K and bringing the position to 15,561 shares worth $5.63M. The position accounts for 0.43% of the portfolio, ranked #60.

Stonebridge Financial Group (Pennsylvania) first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 2,749 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Stonebridge Financial Group (Pennsylvania) held 15,561 shares of Amgen worth $5.63M as of Q2 2026.
  • Stonebridge Financial Group (Pennsylvania) bought 498 Amgen shares in Q2 2026, an estimated $170K.
  • Amgen made up 0.43% of Stonebridge Financial Group (Pennsylvania)'s portfolio in Q2 2026, its #60 holding.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 2,749 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2026, filed 6 Jul 2026.